-
Views
-
Cite
Cite
Rosângela Stadnick Lauth de Almeida Torres, Talita Zajac dos Santos, Robson Antônio de Almeida Torres, Lygia Maria Coimbra de Manuel Petrini, Marion Burger, Andrew C. Steer, Pierre R. Smeesters, Management of Contacts of Patients With Severe Invasive Group A Streptococcal Infection, Journal of the Pediatric Infectious Diseases Society, Volume 5, Issue 1, March 2016, Pages 47–52, https://doi.org/10.1093/jpids/piu107
Close - Share Icon Share
Abstract
Conflicting recommendations regarding antibiotic prophylaxis for contacts of patients with invasive group A streptococcal (GAS) infection exist. Close contacts of patients with such severe and rapidly progressive disease often strongly appeal to the treating clinicians for antimicrobial treatment to prevent additional cases. We aimed to use an approach based on pharyngeal culture testing of contacts and targeted antibiotic prophylaxis.
A large throat swab survey including 105 contacts was undertaken after a fulminant and fatal case of GAS necrotizing fasciitis. GAS strains were characterized by emm typing and antimicrobial susceptibility to 7 antibiotics. The presence of 30 virulence determinants was determined by polymerase chain reaction and sequencing.
The GAS isolate recovered from the index patient was an M1T1 GAS clone susceptible to all antimicrobial agents tested. The same clone was present in the throat of 36% of close contacts who had exposure to the index patient (family households and classroom contacts) for >24 hours/week, whereas the strain was present in only 2% of the other contacts.
Although the study does not allow firm conclusions to be drawn as to whether antibiotic prophylaxis is effective, we describe a practical approach, including an educational campaign and targeted antibiotic treatment to close contacts who have been exposed to an index patient for > 24 hours/week before the initial disease onset.
